CME Outfitters Podcasts http://podcast.nscmeblog.com/ CME Outfitters podcasts Podcast Generator 2.6 - http://podcastgen.sourceforge.net Thu, 21 Sep 2017 06:02:22 -0600 en CME Outfitters LLC - 2006 - 2015 http://podcast.nscmeblog.com/images/itunes_image.jpg CME Outfitters Podcasts http://podcast.nscmeblog.com/ CME Outfitters podcasts Improving Clinical Practice... One Change at a Time CME Outfitters, LLC CME Outfitters, LLC tmeyers@cmeoutfitters.com clean Engaging Patients to Optimize Outcomes in Gastroesophageal Reflux Disease Cash, Chey, Shaheen The prevalence of gastroesophageal reflux disease (GERD) appears to be rising. The etiology of this increasing prevalence is multifactorial and includes effects of obesity, high calorie intake, and sedentary lifestyle. Patients with GERD and nocturnal reflux have worse quality of life than healthy individuals due to their impaired function during the day.

]]>
Cash, Chey, Shaheen http://podcast.nscmeblog.com/?name=2015-06-16_mmv061.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mmv061.mp4 1:31:30 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC GERD, CME, CNE, Asian, reflux, nocturnal, sleep, pain, treatment, guideline, digestive, disease, gastroenterologist, pharmacokinetic, therapeutic no Mon, 15 Jun 2015 16:36:00 -0600
Engaging Patients to Optimize Outcomes in Gastroesophageal Reflux Disease Cash, Chey, Shaheen The prevalence of gastroesophageal reflux disease (GERD) appears to be rising. The etiology of this increasing prevalence is multifactorial and includes effects of obesity, high calorie intake, and sedentary lifestyle. Patients with GERD and nocturnal reflux have worse quality of life than healthy individuals due to their impaired function during the day.

Supported by an educational grant from Takeda Pharmaceuticals International, Inc., U.S. Region.

]]>
Cash, Chey, Shaheen http://podcast.nscmeblog.com/?name=2015-06-16_mmv0611.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mmv0611.mp4 1:31:30 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC GERD, CME, CNE, Asian, reflux, nocturnal, sleep, pain, treatment, guideline, digestive, disease, gastroenterologist, pharmacokinetic, therapeutic no Mon, 15 Jun 2015 04:52:00 -0600
Exploring Treatment Options for Psoriasis Armstrong, Borenstein Psoriasis is an inflammatory, autoimmune disorder with predominately joint and skin symptoms characterized by scaling and erythematous plaques that may be painful or severely pruritic, and may cause significant quality of life issues.

]]>
Armstrong, Borenstein http://podcast.nscmeblog.com/?name=2015-06-16_363475648.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_363475648.mp4 25:24 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Treatment guidelines, psoriasis, screening guidelines, skin diseases, autoimmune diseases, joint destruction, quality of life, dermatology no Fri, 12 Jun 2015 16:31:00 -0600
Coordinating Care Between Dermatologists and Rheumatologists to Improve Outcomes in Patients with Psoriatic Arthritis Podcast Episode Psoriatic arthritis (PsA) occurs in approximately 30% of patients with psoriasis.1 The skin manifestation of psoriasis precedes joint disease in 85% of patients by an average of 12 years.2 Because of the significant incidence of PsA in patients with psoriasis, and because there is a long delay in the onset of symptoms, it is essential that dermatologists screen for and recognize the early symptoms of PsA.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-17_tv-082liveshow_qanda_small-sd.mp4 http://podcast.nscmeblog.com/?name=2015-06-17_tv-082liveshow_qanda_small-sd.mp4 1:28:11 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Psoriatic arthritis, PSA, skin, psoriasis no Fri, 01 May 2015 00:50:00 -0600
Treatment of Ulcerative Colitis for Improved Patient Outcomes and Quality of Life Podcast Episode Patients with ulcerative colitis are managed on long-term medications to maintain remission and mucosal healing. Patients may not understand the importance of maintaining therapy once they begin to feel better. Further, patients may experience side effects and may quit their medication or not take as prescribed. To improve patient adherence, health care professionals must explain the rationale for long-term therapy and explain how to manage side effects.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-17_sn-067-sd.mp4 http://podcast.nscmeblog.com/?name=2015-06-17_sn-067-sd.mp4 27:49 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC ulcerative colitis, healing, mucosal, remission, therapy no Wed, 15 Apr 2015 00:26:00 -0600
Novel Treatment of IBD Informed by Science and Patient Choice: Identifying Primary vs. Secondary Non-Response to Treatment Cohen, Lichtenstein, Regueiro Supported by an educational grant from Takeda Pharmaceuticals International, Inc., U.S. Region.

]]>
Cohen, Lichtenstein, Regueiro http://podcast.nscmeblog.com/?name=2015-06-16_tv080_2.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_tv080_2.mp4 1:32:07 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Inflammatory bowel disease, personalized medicine, evaluation of side effects, treatment failure evaluation, ulcerative colitis, immunopathophysiology, lymphocyte trafficking no Thu, 02 Apr 2015 00:00:00 -0600
Novel Treatment of Inflammatory Bowel Disease Informed by Science and Patient Choice Podcast Episode Inflammatory bowel disease (IBD), which consists of Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gut, which develops because of an excessive immune response to the normal gut flora in a genetically susceptible host.1 Current therapies for IBD have not, as yet, been able to prevent the need for surgical intervention in more than 50% of IBD patients. Education to clinicians who manage patients with moderate-to-severe IBD about the immunopathophysiology of IBD and the latest available options to individualize IBD treatment can reduce the use of corticosteroids and need for hospitalizations or surgery resulting in improved quality of life for these patients. Clinicians often treat IBD based only on diagnosis rather than considering an individual’s uniqueness, personal history, risk factors, genetics, possible immunopathogenesis, and the natural history of the disease.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-17_tv080.mp4 http://podcast.nscmeblog.com/?name=2015-06-17_tv080.mp4 1:32:07 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC IBD, risk factors, personal history, disease, patients no Wed, 11 Mar 2015 00:59:00 -0600
Bipolar Depression Case Series-The Art and Science of Clinical Management: Adjusting and Monitoring Treatment Toward Remission Podcast Episode Bipolar disorder is one of the world’s 10 most disabling conditions, taking away years of healthy functioning from individuals who have the illness. According to Judd and colleagues, individuals with bipolar disorder spend most of their time in a symptomatic, depressed phase. In fact, a significantly greater percentage of time is spent in a depressed mood than in mania, hypomania, or euthymia.1 Individuals with bipolar disorder are at high risk for comorbid medical disorders such as metabolic or cardiovascular disorders, and unfortunately, several of the psychotropic medications that are used to treat bipolar disorder may increase the risk of developing certain medical illnesses. Careful, ongoing assessment, monitoring and allows for individualized treatment-selection that can help reduce some of the treatment-related risk factors and improve quality of life for these patients.2

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_tv79segment_2.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_tv79segment_2.mp4 20:08 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC euthymia, hypomania, mania, mood, disorders no Thu, 05 Feb 2015 00:37:00 -0700
Bipolar Depression Case Series-The Art and Science of Clinical Management: Treatment Choices and Monitoring Change Podcast Episode Bipolar disorder is one of the world’s 10 most disabling conditions, taking away years of healthy functioning from individuals who have the illness. According to Judd and colleagues, individuals with bipolar disorder spend most of their time in a symptomatic, depressed phase. In fact, a significantly greater percentage of time is spent in a depressed mood than in mania, hypomania, or euthymia.1 Individuals with bipolar disorder are at high risk for comorbid medical disorders such as metabolic or cardiovascular disorders, and unfortunately, several of the psychotropic medications that are used to treat bipolar disorder may increase the risk of developing certain medical illnesses. Careful, ongoing assessment, monitoring and allows for individualized treatment-selection that can help reduce some of the treatment-related risk factors and improve quality of life for these patients.2

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-17_tvs79egment_1_640.mp4 http://podcast.nscmeblog.com/?name=2015-06-17_tvs79egment_1_640.mp4 25:21 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC ilness, medications, risk no Thu, 05 Feb 2015 00:21:00 -0700
The Art and Science of Intrathecal Pain Management Podcast Episode Intrathecal (IT) therapy has become an increasingly accepted alternative to standard medical management for patients with moderate-to-severe intractable pain. Suitable patient and treatment selections are imperative for achieving optimum outcome.1 However, even in the right patient, the right drug may not be efficacious or may result in intolerable adverse effects if the treatment is not initiated properly. Evidence suggests that ongoing education is warranted to build and strengthen the use of evidence-based, best practices among clinicians regarding use of IT therapy in pain management.2

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_cmeo_nans_dec_2014_final-1.m4v http://podcast.nscmeblog.com/?name=2015-06-16_cmeo_nans_dec_2014_final-1.m4v 1:02:07 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC pain, IT, Intrathecal, drug, pain management no Wed, 21 Jan 2015 22:52:00 -0700
Remission in MDD: What Does the Future Hold for Clinicians and Patients? Podcast Episode Although many antidepressants are available to treat major depressive disorder (MDD), as many as 70% of patients diagnosed with MDD do not reach remission even after receiving an adequate course of treatment.1 Remission is currently being redefined. The outcome measure that is generally reported in clinical trials "has been arbitrarily defined as a symptom reduction of 50% or greater from pretreatment in total symptom severity."2 Yet, a response that does not achieve an asymptomatic remitted state "constitutes an unsatisfactory outcome in that it includes patients with ongoing, clinically significant disease activity. While symptomatic remission increases the probability for recovery in MDD. Available evidence indicates that the majority of individuals with MDD receiving guideline-concordant and measurement-based care do not achieve and sustain a fully remitted state with index antidepressant treatment.

Supported by an educational grant from Otsuka America Pharmaceutical, Inc.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_tv081_640.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_tv081_640.mp4 1:33:07 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Major depressive disorder, unipolar depression, mood disorder, remission, treatment resistant depression, psychopharmacology, atypical antipsychotic, augmentation, treatment strategies no Wed, 07 Jan 2015 00:01:00 -0700
Bipolar Depression Case Series: The Art and Science of Clinical Management Podcast Episode Bipolar disorder is one of the world’s 10 most disabling conditions, taking away years of healthy functioning from individuals who have the illness. According to Judd and colleagues, individuals with bipolar disorder spend most of their time in a symptomatic, depressed phase. In fact, a significantly greater percentage of time is spent in a depressed mood than in mania, hypomania, or euthymia.1 Individuals with bipolar disorder are at high risk for comorbid medical disorders such as metabolic or cardiovascular disorders, and unfortunately, several of the psychotropic medications that are used to treat bipolar disorder may increase the risk of developing certain medical illnesses. Careful, ongoing assessment, monitoring and individualized treatment-selection can help reduce some of the risk factors and improve quality of life for these patients.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_tv-079.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_tv-079.mp3 2:54 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Depression, bipolar depression, antipsychotic, metabolic, measurement-based care, unipolar depression, bipolar disorder no Mon, 15 Dec 2014 23:32:00 -0700
Bipolar Depression Case Series-The Art and Science of Clinical Management: Balancing Efficacy and Safety Podcast Episode Bipolar disorder is one of the world’s 10 most disabling conditions, taking away years of healthy functioning from individuals who have the illness. According to Judd and colleagues, individuals with bipolar disorder spend most of their time in a symptomatic, depressed phase. In fact, a significantly greater percentage of time is spent in a depressed mood than in mania, hypomania, or euthymia.1 Individuals with bipolar disorder are at high risk for comorbid medical disorders such as metabolic or cardiovascular disorders, and unfortunately, several of the psychotropic medications that are used to treat bipolar disorder may increase the risk of developing certain medical illnesses. Careful, ongoing assessment, monitoring and individualized treatment-selection can help reduce some of the risk factors and improve quality of life for these patients.2 Evaluating the risk factors for medications during pregnancy is a challenge for clinicians and needs to be part of a shared decision process with patients.3 On December 15, 2014, a neuroscienceCME Live and On Demand featured series of cases on bipolar depression. To meet the learning preferences of busy clinicians, the activity has been divided into three short modules, each featuring a patient case that demonstrates the complex challenges of presented by patients with bipolar depression

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_tv79_segment_3.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_tv79_segment_3.mp4 21:32 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC disease, ongoing assessment, patients no Mon, 15 Dec 2014 00:45:00 -0700
Hepatitis B Virus Reading Room Podcast Episode Podcast Episode

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_jc018_live_112014.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_jc018_live_112014.mp3 57:40 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC hepatitis, HPV, HEPB no Thu, 20 Nov 2014 12:32:00 -0700
Optimizing Care for the Management of Benign Prostatic Hyperplasia McVary, Carson, Kaplan, Staskin Prostate enlargement, or benign prostatic hyperplasia (BPH), is an important men’s health condition. Over eight million men (above the age of 50) in the United States alone are undergoing treatment for BPH, but many more have the condition. BPH shows increasing incidence and prevalence with age, affecting over half of men over age 60, and 90% of those over age 85.

]]>
McVary, Carson, Kaplan, Staskin http://podcast.nscmeblog.com/?name=2015-06-16_05-17-14_cme_orlando__revised_2.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_05-17-14_cme_orlando__revised_2.mp4 1:11:22 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC BPH, prostate, benign prostastic hyperplasia, erectile dysfunction, urology, LUTS, lower urinary tract symptoms, pathophysiology, treatment, men’s health, older men no Sat, 17 May 2014 05:33:00 -0600
Late-Life Depression: More Than a Mood Disorder Podcast Episode Major depressive disorder (MDD) is the most prevalent mental health condition and late-life depression is associated with significant morbidity and mortality and a tendency towards chronicity.(1) Depression in a geriatric population presents a unique set of challenges to the treating clinician. MDD adversely affects the brain and can be manifested as disturbed cognitive function, disrupted sleep, appetite disturbance, and behavioral abnormalities in addition to the alteration of mood.(2)

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-17_mmv-050_video_2.mp4 http://podcast.nscmeblog.com/?name=2015-06-17_mmv-050_video_2.mp4 1:25:53 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC major depressive disorder, MDD, health, morbidity, cognitve no Tue, 06 May 2014 02:43:00 -0600
Late-Life Depression: More Than a Mood Disorder Nelson, Steffens Major depressive disorder (MDD) is the most prevalent mental health condition and late-life depression is associated with significant morbidity and mortality and a tendency towards chronicity.(1) Depression in a geriatric population presents a unique set of challenges to the treating clinician. MDD adversely affects the brain and can be manifested as disturbed cognitive function, disrupted sleep, appetite disturbance, and behavioral abnormalities in addition to the alteration of mood.(2)

This enduring replay of the symposium recorded at the 2014 AAGP Annual Meeting integrates patient vignettes to demonstrate the unique challenges and nuances that may complicate the diagnosis and treatment of late-life depression. The voice of the patient will offer an impactful, clinical perspective to the educational activity.

Provided by the American Association for Geriatric Psychiatry. Supported by an educational grant from Takeda Pharmaceuticals International, Inc., U.S. Region and Lundbeck.

]]>
Nelson, Steffens http://podcast.nscmeblog.com/?name=2015-06-16_mmv-050_video_2.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mmv-050_video_2.mp4 1:25:53 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Geriatric, psychiatry, medicine, elderly, cognition, depression, major depressive disorder, treatment resistant depression no Tue, 06 May 2014 02:27:00 -0600
Strategies for Success in Intrathecal Pain Management Caraway, McDowell Optimal pain management is a national healthcare priority and we have come a long way in improving the safe and effective use of opioid therapy for patients with both acute and chronic pain. However, for many patients with chronic pain that is severe and intractable, oral opioid therapy is not enough; other options are better suited to achieving pain control. One such option is intrathecal (IT) therapy, which is becoming an increasingly accepted strategy for using both opioid and non-opioid analgesics, and neuromodulators, for the management of intractable pain in appropriate patients. Applying evidence-based patient selection criteria is central to achieving success as are integrating trialing and individualizing the titration schedule for each patient. This symposium will provide the evidence and insight that are warranted to build and strengthen clinicians’ confidence and skill in the use of IT pain therapy.

Supported by an educational grant from Jazz Pharmceuticals, Inc.

]]>
Caraway, McDowell http://podcast.nscmeblog.com/?name=2015-06-16_mm-052android.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mm-052android.mp4 58:54 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC intrathecal drug delivery, ziconotide, morphine, pain management, trialing no Wed, 30 Apr 2014 01:39:00 -0600
Neurocognitive Disorders, the DSM-5, and Informed Treatment Choices Podcast Episode Changes to the DSM-5 have modified the language used in evidence-based diagnostic criteria for dementia(1) and education for clinicians can accelerate both the adoption of this new language and how to apply these revisions to clinical practice.(1) The National Institutes of Health’s (NIH) National Institute on Aging Alzheimer’s Disease (NIAAD) Research Summit 2013 reported that the management of Alzheimer's disease needs to be viewed as a continuum that begins up to one decade before the symptoms form an obvious, clinical entity. The Summit further reported that Alzheimer's disease is a multifaceted disease, and there is much more that clinicians can do much more than they currently over the course of the disease to work to change its course.

Provided by the American Association for Geriatric Psychiatry. Supported by an educational grant from Forest Research Institute, Inc., a wholly-owned subsidiary of Forest Laboratories Inc.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_mm-054_aagp-alz_small.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mm-054_aagp-alz_small.mp4 1:24:53 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Dementia, neurocognitive disorders, neurocognition, Alzheimer’s disease, DSM-5, diagnostic criteria, nomenclature, cholinesterase inhibitor, memantine, cognitive impairment, geriatric, memory problems no Sun, 16 Mar 2014 23:09:00 -0600
Gaining Ground in Men's Genitourinary Health: Maximizing Outcomes for Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction Rosenberg This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com. 

]]>
Rosenberg http://podcast.nscmeblog.com/?name=2015-06-16_mmv-049.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mmv-049.mp4 47:45 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Urology, prostate, benign prostatic hypertrophy, benign prostatic hyperplasia, BPH, erectile dysfunction, ED, impotence, prostatitis no Fri, 23 Aug 2013 23:10:00 -0600
RLS for RLS: Resources, Learnings, and Strategies for Improving Outcomes in Restless Legs Syndrome Podcast Episode When appropriately treated, patients with restless legs syndrome (RLS) can experience good benefits of therapy, leading to improved quality of life. However, evidence suggests that RLS remains underdiagnosed and undertreated in routine clinical practice. Undertreatment of RLS has negative effects on sleep and daytime activities; these can affect personal, family, and occupational life. Ongoing education is warranted to improve evidence-based and appropriate treatment of RLS. New practice guidelines are available; nonetheless, ongoing clinical challenges exist regarding the selection and optimization of treatment. In addition, patients require counseling when starting dopamine agonists, and clinicians may not be prepared to provide this support.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_jc-017_final.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_jc-017_final.mp3 55:26 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC RLS, restless legs, therapy, personal, family no Wed, 10 Jul 2013 06:26:00 -0600
Improving Medication Adherence and Outcomes in Transplant Recipients: The Impact of Medication Nonadherence Podcast Episode Patients’ adherence to prescribed medication regimens is a challenge in many patients who have a chronic illness and the need for ongoing treatment. Fewer than half of individuals who are chronically ill actually adhere to prescribed medication regimens. Continuity of recommended post-surgical care is especially important in transplantation.(1) Lack of adherence to immunosuppressive medication increases the transplant recipients’ likelihood of graft rejection or failure. Non-adherence can also cause increased health complications, health care costs, and deaths.(2) Adherence to immunosuppressive medication after transplantation is important to maximize good clinical benefits and outcomes; however, adherence remains suboptimal and not well-understood. Clinicians need to proactively partner with patients to educate each other and work together toward patient health and the success of a transplant.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_mmv1-046_640x480.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_mmv1-046_640x480.mp4 27:51 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC transplant, surgical, health care, medication no Fri, 28 Jun 2013 23:19:00 -0600
Bipolar Depression - Clinical Management in the Community Podcast Episode An accurate diagnosis is, of course, the first step in making treatment decisions. Treatment choices in psychiatry are rarely straightforward, and bipolar depression is no exception to this general rule. Further, the number of FDA-approved medications for bipolar mania has tripled over the past decade, while the pharmacopoeia available for bipolar depression remains quite limited.(1) Treating bipolar depression requires an individualized care plan. The construction of a care plan is further complicated by the limited number of FDA-approved medications. There are few reliable indicators of clinical efficacy to guide the treatment decisions; thus, each option should be discussed with the patient, including initiation and maintenance of therapy.(2) The final choice is often driven by which medication is likely to be best tolerated. In addition, psychotherapy has been shown to be an effective adjunctive treatment for bipolar depression.(1)

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_cr-015_final.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_cr-015_final.mp3 53:18 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC psychotherapy, bipolar, depression no Wed, 26 Jun 2013 23:32:00 -0600
Strategies to Improve Adherence and Clinical Management of Overactive Bladder: Prevalence of OAB and Impact on Quality of Life Podcast Episode High discontinuation rates present a substantial barrier to achieving optimal outcomes in all chronic conditions requiring long-term, consistent pharmacotherapy. Discontinuation rates of 80%-90% within the first year of therapy have been reported for overactive bladder (OAB) medications.(1) In order to improve adherence and quality of life for patients with OAB, a proactive and multifaceted approach is needed by clinicians. Frequent and open discussions about side effects or other barriers to pharmacological treatment, or to modify treatment plans and medications can improve adherence. Recommending combined behavioral, psychosocial, and pharmacological therapies along with routine discussions about adherence to treatment can improve the dialogue about the overall management of OAB. On May 4, 2013, CME Outfitters presented a case-based, interactive symposium featuring a panel that focused on strategies to empower patients in their care with the goal of improving patients’ adherence to the recommended treatments for OAB. To meet the learning preferences of busy clinicians, the symposium has been divided into three short modules, each featuring a video patient case that demonstrates the complex challenges of treatment and medication adherence in patients with OAB at various stages of life—a working mother, a man with complex medical issues, and an elderly woman. Module 1: Prevalence and Impact on Quality of Life Click here to begin activity now Module 2: Treatment Click here to access this activity Module 3: Medication Adherence Click here to access this activity Each module is certified for .5 AMA PRA Category 1 Credit™. We encourage participants to complete all three modules to optimize the learning experience and to gain valuable insights for treating their patients with OAB.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=mm-047_segment_1_646x3601.mp4 http://podcast.nscmeblog.com/?name=mm-047_segment_1_646x3601.mp4 20:08 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC OAB, Quality of Life, Adherence no Mon, 10 Jun 2013 15:29:00 -0600
Bipolar Depression - Differential Diagnosis in the Community Nemeroff, Calabrese More than one in five primary care patients with depression have bipolar disorder, a recurrent and sometimes chronic illness involving episodes of depression and mania or hypomania. The most frequent presentation is depression; mania, as a presentation, is much less frequently encountered in physicians' offices, both primary care and psychiatric. Bipolar depression is often missed in these situations. About half of patients with bipolar disorder have consulted three or more health care professionals before receiving a correct diagnosis, and the average time to first treatment is 10 years.(1)

This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc.

]]>
Nemeroff, Calabrese http://podcast.nscmeblog.com/?name=2015-06-16_cr-014_edited4-15.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_cr-014_edited4-15.mp3 39:15 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Depression, bipolar depression, unipolar depression, under-recognition, mood disorder, screening tools, bipolar disorder Bipolar Disorder; Mood Disorders; Depressive Disorder no Wed, 24 Apr 2013 22:53:00 -0600
Improving Outcomes: When Infection Is More Than Skin Deep Podcast Episode The number of patients seeking care for skin and soft tissue infections (SSTIs) has been increasing over recent years. Importantly, during this time, antibiotic-resistant bacteria (i.e., “superbugs”) have become an increasing public health problem, and methicillin-resistant Staphylococcus aureus (MRSA) is a leading pathogen. Current practice for complicated SSTIs (cSSTIs) is to assume that cSSTIs are due to MRSA and treat empirically—until proven otherwise—in addition to standard incision and drainage (I & D) of the lesion. However, evidence suggests that the rates at which I & D is performed and appropriate antibiotic coverage for MRSA is provided have room for improvement and can be optimized above current practice. This Journal Club activity features expert faculty discussing a recent peer-reviewed article reporting a prospective, multicenter study on cSSTI management in the journal, BMC Infectious Diseases. Using the article as a springboard, clinicians will explore the continually changing epidemiology of MRSA infection, the rationale supporting gold-standard I & D, and available data that support optimal selection of antimicrobial therapy.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_jc-016_edited_final.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_jc-016_edited_final.mp3 31:27 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC BMC, therapy, cSSTI no Thu, 18 Apr 2013 13:21:00 -0600
Best Primary Care Practices for Hepatitis B Infection: Focus on Therapeutic Strategy Planning and Treatment Counseling Podcast Episode According to the report by the Institute of Medicine entitled Hepatitis and Liver Cancer: Information for Health Care Providers, chronic infection with hepatitis B virus constitutes a public health problem—one that primary care clinicians can play a critical role in addressing. Specifically, the report calls for frontline clinicians to increase screening of at-risk adults, provide better patient education about HBV serologic results, and strengthen efforts toward patient access to treatment and monitoring services. This CME Outfitters Chart Review webcast features national experts as your guides on a patient case expedition that will cover the terrain of current national guidelines from AASLD, emerging data, and expert experience. This Chart Review focuses on primary care-based treatment and counseling before specialist referral. A companion Chart Review covers HBV infection screening and diagnosis. Learners are encouraged to participate in that activity, although it is not a prerequisite for participation in this one. Both Chart Reviews follow a Live and On Demand activity, the flagship experience in the CME Outfitters vWorld™ virtual learning environment.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_cr-013_final_edited.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_cr-013_final_edited.mp3 53:43 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC vworld, aasld, hepatitis, infection, health no Thu, 20 Dec 2012 12:18:00 -0700
New Perspectives on Chronic Pain Podcast Episode According to a recent Institute of Medicine report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, pain is a significant public health problem that costs society at least $560 – $635 billion each year. This amount is equal to about $2,000 for each person living in the United States.(1)

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_sn-046.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_sn-046.mp4 20:57 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC pain, health care, costs no Tue, 11 Dec 2012 11:38:00 -0700
Best Primary Care Practices for Hepatitis B Infection: Focus on Screening and Diagnosis Podcast Episode According to the report issued by the Institute of Medicine entitled Hepatitis and Liver Cancer: Information for Health Care Providers, chronic infection with hepatitis B virus (HBV) constitutes a public health problem—one that primary care clinicians can play a critical role in addressing. Specifically, the report calls frontline clinicians to increase screening of at-risk adults, provide better patient education about HBV serologic results, and strengthen efforts toward patient access to treatment and monitoring services either in primary care or via timely referral to specialist care. This CME Outfitters Chart Review features national experts as your guides on a patient case expedition that will cover the terrain of current national guidelines (from the American Association for the Study of Liver Diseases), emerging data, and expert experience.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_cr-012_final_audio_edited_120612.m4a http://podcast.nscmeblog.com/?name=2015-06-16_cr-012_final_audio_edited_120612.m4a 57:32 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Liver Diseases, HBV, Hepatitis no Thu, 06 Dec 2012 23:21:00 -0700
Restless Legs Syndrome: Underdiagnosed & Undertreated Nemeroff, McCall Restless legs syndrome (RLS), a sensorimotor disorder, spans the boundaries of neurology, sleep medicine, and psychiatry. Although common, this life-altering condition is often unrecognized and undiagnosed, leaving patients with a decreased quality of life. The diagnosis of RLS is clinical and does not require polysomnographic findings. The dysesthesias of RLS are associated with an urge to move; the dysesthesias and urge to move are relieved by movement and are worse in the evening and at night

This activity is supported by an educational grant from UCB, Inc.

]]>
Nemeroff, McCall http://podcast.nscmeblog.com/?name=2015-06-16_sn-048.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_sn-048.mp4 27:25 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Restless legs syndrome, RLS, periodic limb movement disorder, PLMD, dopamine receptor agonist, alpha-2-delta ligand, iron, ferritin, opioids, sleep disorder, movement disorder no Thu, 06 Dec 2012 22:53:00 -0700
Primary Care Management of Neuropathic Pain: Approaches for Accurate Assessment and Appropriate Treatment Podcast Episode Neuropathic pain is a challenge to health care providers because it is often underdiagnosed and undertreated. It may be associated with variable levels of pain, problems with the activities of daily living, impaired quality of life, and functional disabilities.(1) The impact of neuropathic pain is well known to those who have experienced it themselves and to the clinicians who specialize in the care of these patients. Neuropathic pain causes immense suffering that is accompanied, all too often, by a pervasive sense of alienation as the individual moves from doctor to doctor in search of an answer, if not a cure.(1) It has only recently become clear that there is little to match the pain that arises from neuropathic causes. In a landmark study, Melzack and colleagues demonstrated that neuropathic pain exceeded every other cause of pain in the intensity of its effects. Thus possibly more than any other area of medicine, neuropathic pain demands that a thorough scientific knowledge of pain be partnered with the utmost in professional qualities.(2) Neuropathic pain has been a particularly difficult challenge to the research and clinical communities in the overall management because the severity of pain and resistance to treatment.(3)

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_my_movie.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_my_movie.mp4 18:58 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC neuropathic, pain, quality of life, disabilities no Tue, 04 Dec 2012 22:53:00 -0700
Alzheimer's Disease: Current Approaches to Practice Nemeroff, Raskind Evidence-based practice guidelines, such as the American Psychiatric Association’s 2007 Practice Guideline for the Treatment of Patients with Alzheimer’s Disease and Other Dementias, suggest that the strongly support early assessment and intervention.(1) The U. S. Food and Drug Administration approved imaging such as positron emission tomography for Alzheimer’s disease, and this can often inform a diagnosis.(2) In later stages of Alzheimer’s disease, patients experience decreased overall function, have reduced capacity to perform activities of daily living, and frequently exhibit problematic behaviors. Timely assessment and the safe, effective treatment of problematic behavior is always a challenge for the clinician and caregiver.(1)

]]>
Nemeroff, Raskind http://podcast.nscmeblog.com/?name=2015-06-16_sn-049.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_sn-049.mp4 27:59 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Denentias, Alzheimers no Fri, 30 Nov 2012 06:41:00 -0700
The Role of Orexin in the Arousal System: Implications for Sleep-Wake Medicine Nemeroff, McCall Orexins, also called hypocretins, are novel peptides that act as neurotransmitters to modulate several body systems and processes, including the arousal system and wakefulness. First discovered in the late 1990s and initially investigated in narcolepsy, these peptides are now at the center of growing excitement and scientific and clinical discussions related to their implications for therapies in sleep-wake medicine. In particular, the orexin system is serving as a therapeutic target to develop agents for insomnia and narcolepsy.

]]>
Nemeroff, McCall http://podcast.nscmeblog.com/?name=2015-06-16_47.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_47.mp4 21:08 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC orexin, hypocretin, arousal, narcolepsy, sleep-wake, wakefulness, neuropeptide, neurotransmitters, orexin deficiency; Wakefulness/physiology; Arousal/physiology no Thu, 29 Nov 2012 22:53:00 -0700
Changes in Palliative Care and Pain Management Podcast Episode The management of palliative pain for patients with terminal diseases is a multifaceted process that requires the frequent adjustment of both medications for pain itself, e.g., opioids, and for comorbid conditions, e.g., cancer, depression, or chronic obstructive pulmonary disease.(1) Clinicians must learn to manage complex combinations of medications in patients whose health is continuously in decline, a reality that brings to light psychosocial and family dynamics. Furthermore, in order to ensure that treatments are appropriately selected, consideration must be given to the potential for neurotoxicity, as well as to the type of pain occurring in each individual patient.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_sn-033.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_sn-033.mp4 39:45 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC neurotaxicity, pain, palliative pain, terminal disease no Tue, 20 Nov 2012 07:48:00 -0700
Low Back Pain: Diagnosis and Management of the Complex Patient Podcast Episode Low back pain (LBP) is a major cause of chronic pain in the United States; many patients present to their clinician with a major complaint of compromised activities of daily living and impacts on quality of life, leading to functional disability due to LBP. A whole-person approach to management by an interdisciplinary team can reduce the burden of chronic pain and return many patients to near full functionality. Clinicians need to be aware of the red flags or aberrant behaviors that could be dangerous for the patient. In addition, once the medical regimen is simplified, appropriate and comprehensive follow-up helps patients with long-term coping skills.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_sn-029rev2mp4.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_sn-029rev2mp4.mp4 38:22 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC lbp, low back pain, pain, chronic pain no Thu, 15 Nov 2012 06:40:00 -0700
The Complexities of Pain Management in the Extended Care Setting Mestemaker, Grauer, Mason  

CME Outfitters, LLC, gratefully acknowledges an educational grant from Endo Pharmaceuticals and Pfizer Inc. in support of this CE activity.

]]>
Mestemaker, Grauer, Mason http://podcast.nscmeblog.com/?name=2015-06-16_sn032edited1.mp4 http://podcast.nscmeblog.com/?name=2015-06-16_sn032edited1.mp4 25:51 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC Pain, pain assessment, pain management, long-term care, opioids, drug switching, dosing, best practices, pain screening tools, chronic illness, cancer pain, older patients, dementia no Tue, 13 Nov 2012 05:53:00 -0700
Biopsychosocial Model of Chronic Pain Podcast Episode Biopsychosocial pain disorders are, by definition, disorders having three dimensions: biological, psychological, and social. Limiting the evaluation and management of a chronic pain condition to a one-dimensional biological perspective often fails to fully explain the patient’s symptoms. Consequently, assessment and management require not only the examination of the biological dimension but also of the psychological and social dimensions. These two critical aspects of pain in an individual’s life are often overlooked in the routine assessment of pain.

]]>
Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_sn-030.mpg http://podcast.nscmeblog.com/?name=2015-06-16_sn-030.mpg 20:30 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC biopsychosocial, pain, disorder, psychological, pain no Thu, 08 Nov 2012 00:18:00 -0700
MC-001 Weinberger Podcast Episode Podcast Episode http://podcast.nscmeblog.com/?name=2015-06-16_mc-001_weinberger.mp3 http://podcast.nscmeblog.com/?name=2015-06-16_mc-001_weinberger.mp3 48:56 tmeyers@cmeoutfitters.com (CME Outfitters, LLC) CME Outfitters, LLC no Wed, 16 Jun 2010 23:32:00 -0600